RWA
GHDX

River Wealth Advisors’s Genomic Health, Inc. GHDX Stock Holding History

River Wealth Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed -$13K – 552
2018
Q4 		$13K Hold
200
– – 0.01% 394
2018
Q3 		$14K Hold
200
– – 0.01% 424
2018
Q2 		$10K Buy
+200
New +$7.94K ﹤0.01% 450

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

River Wealth Advisors's GHDX Position: Q1 2019 in Review

River Wealth Advisors sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 200 shares — an estimated $13K sold.

River Wealth Advisors first reported a position in GHDX in Q2 2018 and held it in 3 quarters. The position peaked at $14K in Q3 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • River Wealth Advisors reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
  • River Wealth Advisors sold 200 Genomic Health, Inc. shares in Q1 2019, an estimated $13K.
  • River Wealth Advisors first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 3 quarters.
  • River Wealth Advisors's Genomic Health, Inc. position peaked at $14K in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on River Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.